Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Radiation Oncology
Published in: Journal of Radiation Oncology 3/2019

01-09-2019 | Original Research

Impact of choice of dose calculation algorithm on PTV and OAR doses in lung SBRT

Authors: Kashmiri L. Chopra, Matthew M. Harkenrider, B. Emami, Edward Melian, Jaiteerth S. Avadhani, T. S. Kehwar, D. V. Rai, Anil Sethi

Published in: Journal of Radiation Oncology | Issue 3/2019

Login to get access

Abstract

Background

Five dose calculation algorithms commonly used in lung SBRT planning are evaluated for their dosimetric impact on planning target volume (PTV) and organ-at-risk (OAR) doses.

Methods and materials

Treatment plans for thirty lung SBRT patients were included in this multi-institutional planning study. Lung SBRT plans were initially generated using BrainLab Pencil Beam (PB) convolution algorithm to deliver 50 Gy in 5 fractions to PTV (PB_OP plans). Plans were recalculated using BrainLab Monte Carlo (MC) algorithm with the same beam parameters, field settings, and MUs (MC_NO plans) to investigate accuracy limits of PB plans. Next, these plans were re-optimized via MU scaling in MC algorithm while keeping original beam parameters and settings (MC_OP). Further, with these new MUs, all patient plans were recalculated with Pinnacle collapsed cone convolution superposition (CCC), Eclipse anisotropic analytic algorithm (AAA), and Eclipse Acuros XB (AXB) algorithms, and are referred to as AP_NO, AAA_NO, and AXB_NO plans, respectively. DVH of PTV and OARs were used to calculate dosimetric parameters for comparison with MC_OP plans. Patient plans were compared based on PTV size as well as the location in the lung: island targets, adjacent to the ribs/chest wall, or mixed.

Results

Lung SBRT plans using PB dose algorithm overestimated target doses by 10–20% of prescribed dose and these differences were highlighted mainly in the target periphery/dose-buildup region as seen in Dmin and D90. Compared with MC, both Pinnacle and AAA plans overestimated PTV dose in the penumbra region, whereas Acuros plans were in good agreement with MC plans. PTV dose differences ranged 3–5% among Pinnacle, AAA, and Acuros. In general, Acuros AXB performed well for adjacent and mixed targets near the ribs and chest wall, whereas Pinnacle CCC was favored for island targets. OAR Dmax and lung V20 were better reproduced in Pinnacle, whereas Dmean were comparable among all TPS.

Conclusion

Knowing the strengths and limitations of clinical treatment planning system allows more consistent and accurate dose comparison for patients enrolled in protocol studies.
Literature
1.
Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 63:37–46CrossRef
2.
Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76:326–332CrossRef
3.
McGarry RC, Papiez L, Williams M et al (2005) Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 63:1010–1015CrossRef
4.
Joyner M, Salter BJ, Papanikolaou N, Fuss M (2006) Stereotactic body radiation therapy for centrally located lung lesions. Acta Oncol 45:802–807CrossRef
5.
Okunieff P, Petersen AL, Philip A, Milano MT, Katz AW, Boros L, Schell MC (2006) Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 45:808–817CrossRef
6.
AAPM Radiation Therapy Committee Task Group no. 65, AAPM Report No. 85 (2004) Tissue inhomogeneity corrections for megavoltage photon beams. Medical Physics Publishing, Madison
7.
Allen Li X, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, Martel MK, Mayo C, Moiseenko V, Nahum AE, Niemierko A, Semenenko VA, Yorke ED (2012) The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys 39(3):1386–1409CrossRef
8.
9.
Lefkopoulos D, Schlienger M, Touboul E, et al. Quantitative evaluation of treatment planning for linac multi-isocentric radiosurgery. Proc. of the XIth Intern. Conf. on: “Computers in radiation therapy,” XIth ICCR, Manchester, UK. 1994; 296–297.
10.
Lefkopoulos D, Dejean C, El-Balma H, et al. Determination of dose-volumes parameters to characterize the conformity of stereotactic treatment plans. Proc. of the XIIIth Intern. Conf. on: “computers in radiation therapy,” XIIIth ICCR, Heidelberg, Germany. 2000; 356–358.
11.
Alite F, Jain S, Sethi A, Melian E, Emami B (2014) Impact of Monte Carlo treatment planning on local control in lung SBRT. Int J Radiat Oncol Biol Phys 90(1):S912CrossRef
12.
Chetty IJ, Curran B, Cygler JE, DeMarco JJ, Ezzell G, Faddegon BA, Kawrakow I, Keall PJ, Liu H, Ma CMC, Rogers DWO, Seuntjens J, Sheikh-Bagheri D, Siebers JV (2007) Report of the AAPM task group no. 105: issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning. Med Phys 34:4818–4853. https://​doi.​org/​10.​1118/​1.​2795842 CrossRefPubMed
13.
Papanikolaou N, Battista JJ, Boyer AL et al (2004) AAPM report 85: tissue inhomogeneity corrections for megavoltage photon beams—report by task group 65 of the Radiation Therapy Committee of the American Association of Physicists in Medicine. Medical Physics Publishing, Madison
14.
Carrasco P, Jornet N, Duch MA, Weber L, Ginjaume M, Eudaldo T, Jurado D, Ruiz A, Ribas M (2004) Comparison of dose calculation algorithms in phantoms with lung equivalent heterogeneities under conditions of lateral electronic disequilibrium: dose calculation algorithms in lung heterogeneities. Med Phys 31:2899–2911CrossRef
15.
Fogliata A, Vanetti E, Albers D, Brink C, Clivio A, Knöös T, Nicolini G, Cozzi L (2007) On the dosimetric behaviour of photon dose calculation algorithms in the presence of simple geometric heterogeneities: comparison with Monte Carlo calculations. Phys Med Biol 52:1363–1385CrossRef
16.
Ojala JJ, Kapanen MK, Hyödynmaa SJ et al (2014) Performance of dose calculation algorithms from three generations in lung SBRT: comparison with full Monte Carlo-based dose distributions. J Appl Clin Med Phys 15:4662PubMed
17.
18.
19.
Ezzell GA, Burmeister JW, Dogan N, LoSasso TJ, Mechalakos JG, Mihailidis D, Molineu A, Palta JR, Ramsey CR, Salter BJ, Shi J, Xia P, Yue NJ, Xiao Y (2009) IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM task group 119. Med Phys 36(11):5359–5373CrossRef
20.
Narayanaswamy G, Saenz DL, Defoor D et al (2017) Dosimetric validation of Monaco treatment planning system on an Elekta VersaHD linear accelerator. J Appl Clin Med Phys 18(6):123–129CrossRef
21.
Snyder JE, Hyer DE, Flynn RT, Boczkowski A, Wang D (2019) The commissioning and validation of Monaco treatment planning system on an Elekta VersaHD linear accelerator. J Appl Clin Med Phys 20(1):184–193CrossRef
Metadata
Title
Impact of choice of dose calculation algorithm on PTV and OAR doses in lung SBRT
Authors
Kashmiri L. Chopra
Matthew M. Harkenrider
B. Emami
Edward Melian
Jaiteerth S. Avadhani
T. S. Kehwar
D. V. Rai
Anil Sethi
Publication date
01-09-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Radiation Oncology / Issue 3/2019
Print ISSN: 1948-7894
Electronic ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-019-00399-7

Other articles of this Issue 3/2019

Journal of Radiation Oncology 3/2019 Go to the issue

Original Research

Evaluating improvements in cardiac dosimetry in breast radiotherapy and comparison of cardiac sparing techniques

Original Research

Therapeutic value of postmastectomy radiation therapy for T1–2 breast cancer with 1–3 positive lymph nodes

Letter to the Editor

Letter to the Editor concerning “Re-irradiation in gynaecological cancers, present experiences and future hopes”

Original Research

Patterns of utilization and comparative efficacy of altered fractionation and concurrent chemoradiation for treatment for T2N0M0 glottic carcinoma

Original Research

Dosimetric evaluation of the dose calculation accuracy of different algorithms for two different treatment techniques during whole breast irradiation

Original Research

Definitive chemoradiation followed by stereotactic body radiotherapy boost for inoperable endometrial cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits